UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$422M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$342M |
| 3 |
Mondelez International
MDLZ
|
+$328M |
| 4 |
SHPG
Shire pic
SHPG
|
+$323M |
| 5 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$258M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$658M |
| 2 |
COL
Rockwell Collins
COL
|
+$266M |
| 3 |
JWN
Nordstrom
JWN
|
+$264M |
| 4 |
Deutsche Bank
DB
|
+$258M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.19% |
| 2 | Technology | 6.4% |
| 3 | Healthcare | 6.06% |
| 4 | Industrials | 4.94% |
| 5 | Consumer Discretionary | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4676
Theravance Biopharma
TBPH
$877M
| $247K | ﹤0.01% |
7,219
+4,794
| +198% | +$157K |
|
4677
CALL
Nu Skin
NUS
$267M
| $246K | ﹤0.01% |
4,000
-36,000
| -90% | -$2.21M |
|
4678
Teekay
TK
$985M
| $245K | ﹤0.01% |
27,350
-6,325
| -19% | -$55.4K |
|
|
HMLP
4679
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $245K | ﹤0.01% |
13,183
+1,798
| +16% | +$33.8K |
|
|
EOCC
4680
DELISTED
Enel Generacion Chile S.A.
EOCC
| $243K | ﹤0.01% |
9,234
-2,170
| -19% | -$52.2K |
|
|
DCOM
4681
DELISTED
Dime Community Bancshares
DCOM
| $243K | ﹤0.01% |
11,280
+5,992
| +113% | +$118K |
|
4682
CALL
Centene
CNC
$32.5B
| $242K | ﹤0.01% |
+5,000
| New | +$215K |
|
4683
Kosmos Energy
KOS
$1.48B
| $242K | ﹤0.01% |
30,336
+5,379
| +22% | +$37.1K |
|
|
KREF
4684
KKR Real Estate Finance Trust
KREF
$499M
| $242K | ﹤0.01% |
11,508
+1,358
| +13% | +$28.3K |
|
|
REVG
4685
DELISTED
REV Group
REVG
| $242K | ﹤0.01% |
8,387
-36,198
| -81% | -$951K |
|
4686
CALL
Lam Research
LRCX
$390B
| $241K | ﹤0.01% |
13,000
-11,000
| -46% | -$178K |
|
4687
ProShares UltraPro MidCap400
UMDD
$35M
| $241K | ﹤0.01% |
12,340
-565
| -4% | -$10.1K |
|
|
SFE
4688
DELISTED
Safeguard Scientifics, Inc.
SFE
| $241K | ﹤0.01% |
18,035
+125
| +0.7% | +$1.54K |
|
|
BFYT
4689
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $241K | ﹤0.01% |
16,614
-16,456
| -50% | -$454K |
|
4690
Lakeland Financial Corp
LKFN
$1.53B
| $240K | ﹤0.01% |
4,930
+4,277
| +655% | +$193K |
|
4691
Coherus Oncology
CHRS
$196M
| $239K | ﹤0.01% |
17,985
+6,148
| +52% | +$81.3K |
|
|
BRG
4692
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $239K | ﹤0.01% |
21,581
-52,933
| -71% | -$606K |
|
4693
Customers Bancorp
CUBI
$2.77B
| $238K | ﹤0.01% |
7,285
+5,940
| +442% | +$171K |
|
|
VIVO
4694
DELISTED
Meridian Bioscience Inc
VIVO
| $238K | ﹤0.01% |
16,625
-477,119
| -97% | -$6.82M |
|
|
TCO
4695
DELISTED
Taubman Centers Inc.
TCO
| $238K | ﹤0.01% |
4,779
-9,330
| -66% | -$512K |
|
4696
Coca-Cola Consolidated
COKE
$12.8B
| $237K | ﹤0.01% |
11,000
+5,250
| +91% | +$116K |
|
4697
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
| $237K | ﹤0.01% |
7,313
+1,355
| +23% | +$44.7K |
|
4698
PUT
Illinois Tool Works
ITW
$85.3B
| $237K | ﹤0.01% |
1,600
+200
| +14% | +$28.4K |
|
|
SDRL
4699
PUT
DELISTED
Seadrill Limited Common Stock
SDRL
| $237K | ﹤0.01% |
2,533
+199
| +9% | +$17.4K |
|
4700
ProShares Ultra MidCap400
MVV
$163M
| $236K | ﹤0.01% |
6,441
-1,986
| -24% | -$68.8K |
|
Similar funds
UBS Group's Q3 2017 Portfolio in Review
As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.
By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.
- UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
- UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
- UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
- UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
- UBS Group opened 749 new positions and closed 707 in Q3 2017.
- UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.
Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.